To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
4SC Announces Further Research Collaboration with Solvay
4SC AG has announced a research collaboration with Solvay Pharmaceuticals GmbH.
The goal of the collaboration is the identification of molecules, which bind to a certain illness-relevant target structure provided by Solvay, and thus building a basis for further development of drug candidates.
By means of a proprietary, computer-based High-Throughput Screening technology, a selection of active substances from 4SC are prepared, which are then examined by Solvay in biological tests.
A first project with a similar project sequence was already agreed upon between 4SC and Solvay last year and completed in December 2005.
"We are very impressed with the quality and the remarkable hit-rate of our first project with 4SC and we look forward to working together further," announced Dr. Dieter Ziegler, Discovery Program Manager Cardiology at Solvay.
"The successful completion of the first project with Solvay is a further proof of the increased recognition of our virtual High-Throughput Screening technology," explained Dr. Ulrich Dauer, CEO of 4SC.
"Therefore, we are very pleased to have attained another collaboration partner with Solvay and to be able to further expand our collaborative efforts."
